Furthermore, we discovered that inhibiting NSUN2 heightened the sensitivity of NSCLC cells to both erastin and RSL3-induced ferroptosis, a shift mediated by the downregulation of NRF2 protein expression. Here, NFE2L2 is linked to non-small cell lung carcinoma.